Shares of Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the nine ratings firms that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $49.4286.
A number of equities analysts recently issued reports on the stock. TD Cowen upped their price objective on shares of Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Wall Street Zen lowered shares of Astrana Health from a “buy” rating to a “hold” rating in a research report on Sunday, August 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Astrana Health in a research note on Thursday, August 27th. Truist Financial upped their price target on shares of Astrana Health from $47.00 to $55.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Finally, Barclays boosted their price objective on Astrana Health from $50.00 to $53.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th.
Check Out Our Latest Analysis on Astrana Health
Astrana Health Stock Performance
Astrana Health (NASDAQ:ASTH – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.34 by $0.46. Astrana Health had a net margin of 1.05% and a return on equity of 10.30%. The firm had revenue of $972.52 million during the quarter, compared to analysts’ expectations of $985.62 million. During the same quarter in the prior year, the business earned $0.19 earnings per share. The business’s revenue for the quarter was up 48.5% compared to the same quarter last year. As a group, analysts expect that Astrana Health will post 1.32 earnings per share for the current fiscal year.
Institutional Trading of Astrana Health
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Corient Private Wealth LP raised its holdings in Astrana Health by 1.6% in the 2nd quarter. Corient Private Wealth LP now owns 24,905 shares of the company’s stock valued at $1,156,000 after buying an additional 399 shares during the last quarter. Swiss National Bank grew its holdings in Astrana Health by 1.2% during the 3rd quarter. Swiss National Bank now owns 86,944 shares of the company’s stock worth $2,465,000 after acquiring an additional 1,000 shares during the last quarter. Public Employees Retirement System of Ohio bought a new stake in Astrana Health during the 2nd quarter worth approximately $51,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Astrana Health by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock valued at $799,000 after acquiring an additional 1,263 shares during the period. Finally, Deutsche Bank AG increased its position in Astrana Health by 3.9% in the 4th quarter. Deutsche Bank AG now owns 41,265 shares of the company’s stock valued at $1,024,000 after acquiring an additional 1,550 shares during the period. 52.77% of the stock is currently owned by institutional investors.
Astrana Health Company Profile
Astrana Health, Inc is a healthcare management and technology company that helps physicians and healthcare organizations deliver value-based care. The company supports provider groups, independent physicians and health systems with clinical, operational and administrative services designed to coordinate care, improve outcomes and manage healthcare costs.
Astrana Health’s platform includes care-management programs, analytics and population-health tools, technology solutions, physician practice support, and services for risk-bearing provider organizations.
Featured Stories
- Five stocks we like better than Astrana Health
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
